← FDA DRUG APPROVALS

FDA NDA · NDA050759

CELLCEPT

mycophenolate mofetil

Sponsor: ROCHE PALO

APPLICATION
NDA050759
TYPE
NDA
ORIGINAL APPROVAL
1998-10-01
LATEST ACTION
2026-07-29
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription

Products

CELLCEPT · ReferencePrescription
MYCOPHENOLATE MOFETIL 200MG/ML · FOR SUSPENSION · ORAL

Approval history

2026-07-29Labeling · Supplement 65 · standardAP
2026-07-29REMS · Supplement 63AP
2025-06-27Labeling · Supplement 61 · standardLetterAP
2024-08-13REMS · Supplement 59LetterAP
2022-08-10Labeling · Supplement 55 · standardLetterAP
2022-06-06Efficacy · Supplement 56 · standardLetterAP
2022-06-06Efficacy · Supplement 54 · standardLetterAP
2021-10-22Labeling · Supplement 50 · standardLetterAP
2021-10-22Labeling · Supplement 51 · standardLetterAP
2021-08-11REMS · Supplement 53LetterAP
2021-04-21REMS · Supplement 52LetterAP
2021-01-15REMS · Supplement 49LetterAP
2019-12-13Labeling · Supplement 45 · standardLabelAP
2019-02-27Labeling · Supplement 43 · standardLetterAP
2018-08-23Labeling · Supplement 41 · standardLabelAP
2017-12-18Labeling · Supplement 42 · standardLabelAP
2015-11-13REMS · Supplement 40LetterAP
2015-07-16Manufacturing (CMC) · Supplement 39 · standardAP
2015-07-09Labeling · Supplement 38 · standardLabelAP
2013-09-27Labeling · Supplement 36 · standardLetterAP
2013-09-27REMS · Supplement 37LetterAP
2013-07-24Manufacturing (CMC) · Supplement 34 · standardAP
2013-02-14Manufacturing (CMC) · Supplement 32 · standardAP
2012-09-25REMS · Supplement 25LetterAP
2012-06-22Labeling · Supplement 33 · standardLabelAP
2012-06-08Labeling · Supplement 31 · standardLetterAP
2009-10-08Labeling · Supplement 28 · unknownLabelAP
2009-06-18Labeling · Supplement 24 · standardLabelAP
2009-02-27Labeling · Supplement 23 · standardLetterAP
2008-12-15Labeling · Supplement 22 · standardLabelAP
2008-05-09Labeling · Supplement 21 · standardLabelAP
2007-12-20Labeling · Supplement 18 · standardLabelAP
2007-09-21Labeling · Supplement 19 · standardLabelAP
2005-10-17Labeling · Supplement 15 · standardLabelAP
2003-02-28Labeling · Supplement 8 · standardLetterAP
2002-12-17Manufacturing (CMC) · Supplement 11 · standardAP
2001-11-21Manufacturing (CMC) · Supplement 10 · standardAP
2001-10-03Manufacturing (CMC) · Supplement 9 · standardAP
2001-02-01Manufacturing (CMC) · Supplement 7 · standardAP
2000-12-20Efficacy · Supplement 5 · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →